Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, glucagon, needles, and other chronic diseases. The Rare Disease segment offers products in the areas of haemophilia, blood disorders, endocrine disorders, growth disorders, and hormone replacement therapy. The company has a collaboration agreement with Gilead Sciences, Inc.; and research collaboration with Novo Nordisk to discover cell-specific carriers of nucleic acid therapeutics. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Novo Nordisk A/S

Intangible Assets

Intangible Assets %Chg

Intangible Assets Common Size

Property, Plant and Equipment

Property, Plant and Equipment %Chg

Property, Plant and Equipment Common Size

Investments in Associated Companies

Investments in Associated Companies %Chg

Investments in Associated Companies Common Size

Deferred Income Tax Assets

Deferred Income Tax Assets %Chg

Deferred Income Tax Assets Common Size

Other Receivables and Prepayments

Other Receivables and Prepayments %Chg

Other Receivables and Prepayments Common Size

Other Financial Assets

Other Financial Assets %Chg

Other Financial Assets Common Size

Total Non-Current Assets

Total Non-Current Assets %Chg

Total Non-Current Assets Common Size

Inventories

Inventories %Chg

Inventories Common Size

Trade Receivables

Trade Receivables %Chg

Trade Receivables Common Size

Tax Receivables

Tax Receivables %Chg

Tax Receivables Common Size

Marketable Securities

Marketable Securities %Chg

Marketable Securities Common Size

Derivative Financial Instruments

Derivative Financial Instruments %Chg

Derivative Financial Instruments Common Size

Cash at Bank

Cash at Bank %Chg

Cash at Bank Common Size

Other Current Assets

Other Current Assets %Chg

Other Current Assets Common Size

Total Current Assets

Total Current Assets %Chg

Total Current Assets Common Size

Total Assets

Total Assets %Chg

Total Assets Common Size

Share Capital

Share Capital %Chg

Share Capital Common Size

Treasury Shares

Treasury Shares %Chg

Treasury Shares Common Size

Retained Earnings

Retained Earnings %Chg

Retained Earnings Common Size

Other Reserves

Other Reserves %Chg

Other Reserves Common Size

Total Equity

Total Equity %Chg

Total Equity Common Size

Borrowings

Borrowings %Chg

Borrowings Common Size

Deferred Income Tax Liabilities

Deferred Income Tax Liabilities %Chg

Deferred Income Tax Liabilities Common Size

Retirement Benefit Obligations

Retirement Benefit Obligations %Chg

Retirement Benefit Obligations Common Size

Other Liabilities

Other Liabilities %Chg

Other Liabilities Common Size

Provisions

Provisions %Chg

Provisions Common Size

Total Non-Current Liabilities

Total Non-Current Liabilities %Chg

Total Non-Current Liabilities Common Size

Cash and Cash Equivalents

Cash and Cash Equivalents %Chg

Cash and Cash Equivalents Common Size

Short-Term Investments

Short-Term Investments %Chg

Short-Term Investments Common Size

Total Cash and Cash Equivalents

Total Cash and Cash Equivalents %Chg

Total Cash and Cash Equivalents Common Size

Accounts Receivable

Accounts Receivable %Chg

Accounts Receivable Common Size

Other Receivables

Other Receivables %Chg

Other Receivables Common Size

Total Trade Receivables

Total Trade Receivables %Chg

Total Trade Receivables Common Size

Net Property, Plant & Equipment

Net Property, Plant & Equipment %Chg

Net Property, Plant & Equipment Common Size

Net Intangible Assets

Net Intangible Assets %Chg

Net Intangible Assets Common Size

Long-Term Investments

Long-Term Investments %Chg

Long-Term Investments Common Size

Other Long-Term Assets

Other Long-Term Assets %Chg

Other Long-Term Assets Common Size

Accounts Payable

Accounts Payable %Chg

Accounts Payable Common Size

Trade Payables

Trade Payables %Chg

Trade Payables Common Size

Accrued Expenses

Revenue

EBIT

EBITDA

CapEx

Net Interest Income

Assets

Adjusted EBITDA

Gross Profit

Adjusted Net Income

Net Revenue

Net Income

Average Assets

Adjusted EBIT

Adjusted Revenue

Adjusted EBT

Adjusted Funds From Operations

Assets	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24
Cash and Cash Equivalents	32,084	18,435	38,938	15,655	57,018	52,821
Cash at Bank
Short-Term Investments	9,922	12,775	6,238	16,979	20,569	12,193
Marketable Securities
Derivative Financial Instruments
Total Cash and Cash Equivalents	42,006	31,210	45,176	32,634	77,587	65,014
Accounts Receivable	75,421	69,575	69,459	71,949	66,299	63,565
Trade Receivables
Other Receivables	22,029	20,707	20,944	19,481	15,786	14,743
Tax Receivables
Other Receivables and Prepayments
Other Receivables and Prepayments
Total Trade Receivables	97,450	90,282	90,403	91,430	82,085	78,308
Inventories	47,504	45,652	42,853	40,849	37,944	36,356
Inventories
Other Current Assets	—	—	—	—	—	—
Other Current Assets
Total Current Assets	181,883	162,705	174,395	160,897	195,160	177,500
Total Current Assets
Net Property, Plant & Equipment	193,244	180,758	172,376	162,488	119,832	109,980
Property, Plant and Equipment
Net Intangible Assets	106,587	107,866	109,379	111,090	54,488	55,501
Intangible Assets
Long-Term Investments	2,725	2,638	2,700	2,677	2,047	1,659
Investments in Associated Companies
Other Financial Assets
Other Long-Term Assets	22,772	23,747	26,275	24,627	23,458	22,565
Deferred Income Tax Assets
Other Receivables and Prepayments
Total Assets	512,288	482,153	489,162	465,795	397,441	369,383
Total Assets

Liabilities	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24
Accounts Payable	23,904	28,206	19,576	28,846	24,079	29,759
Trade Payables
Accrued Expenses	41,068	32,987	58,606	38,016	30,653	29,953
Other Liabilities
Other Liabilities
Short-Term Debt	3,547	5,329	2,392	7,531	4,481	2,363
Borrowings
Derivative Financial Instruments
Other Current Liabilities	22,335	16,927	15,501	9,716	14,651	5,906
Tax Payables
Provisions
Total Current Liabilities	234,358	207,522	236,117	217,528	208,358	187,909
Total Current Liabilities
Long-Term Debt	101,214	99,268	118,723	102,787	56,972	57,060
Borrowings
Borrowings
Other Long-Term Liabilities	150,324	131,370	135,824	135,413	146,083	131,820
Deferred Income Tax Liabilities
Retirement Benefit Obligations
Provisions
Provisions
Provisions
Other Liabilities
Total Long-Term Liabilities	108,034	106,565	114,505	104,781	68,561	68,952
Total Non-Current Liabilities
Total Liabilities	342,392	314,087	350,622	322,309	276,919	256,861
Total Liabilities

Equity	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24
Common Stock	446	446	446	446	446	446
Share Capital
Treasury Stock	-2	-2	-2	-2	-1	-1
Treasury Shares
Accumulated Other Comprehensive Income	923	3,169	777	-1,406	-1,593	-73
Other Reserves
Retained Earnings	168,529	164,453	137,319	144,448	121,670	112,150
Retained Earnings
Total Common Shareholders' Equity	169,896	168,066	138,540	143,486	120,522	112,522
Total Equity
Total Shareholders' Equity	169,896	168,066	138,540	143,486	120,522	112,522
Total Liabilities and Shareholders' Equity	512,288	482,153	489,162	465,795	397,441	369,383
Total Equity and Liabilities